NPPA fixes prices of anti-diabetes drugs

NPPA takes initiative to make healthcare easily accessible to every Indian home

The busy lifestyle and irregular health habits have led to many health issues. Among these, the most common is diabetes. We all are familiar with the fact that the cost of medicines for diabetes takes a toll on our pockets.
In order to make the medicines cheaper for the common man, the drug price regulator National Pharmaceutical Pricing Authority (NPPA) on Monday has fixed the ceiling prices of 12 anti-diabetic generic drugs.
NPPA in a tweet mentioned that the reason behind fixing the prices of diabetes medicines was to make diabetes medicine accessible to all.
Glimepiride tablets, glucose injection and intermediate-acting insulin solutions are included in the list.
In order to make the medicines cheaper for the common man, the drug price regulator National Pharmaceutical Pricing Authority (NPPA) on Monday has fixed the ceiling prices of 12 anti-diabetic generic drugs. because it is important
The price of glimepiride tablets having the strength of 1 mg has been at Rs 3.6 per tablet, while that for 2 mg is Rs5.72 per tablet.
Representational image.
Image: Representational image.
The ceiling price of 1 ml glucose injection having 25% strength has been fixed at 17 paise, while that of 1 ml of insulin (soluble) injection of strength 40IU/ml has been fixed at Rs 15.09.
Similarly, 1ml of intermediate-acting NPH solution insulin injection of strength 40IU/ml has been fixed at a ceiling price of Rs 15.09 and that of 1 ml of premix insulin 30:70 injection (regular NPH) injection of strength 40IU/ml is also Rs 15.09.
The price of 1000mg of metformin has been set at Rs3.66 per tablet. Metformin having the strength of 500mg will now be available at a ceiling price of Rs 1.92.



Be the first to start a discussion here. Sign-in to write a comment now!